Education
About Us
Working with TipRanks
Follow Us
Entheon Biomedical (DE:1XU)
FRANKFURT:1XU
1XU Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.04 - €0.26
Previous CloseN/A
Volume0.00
Average Volume (3M)171.00
Market Cap
$971.03K
Enterprise Value€14.46M
Total Cash (Recent Filing)$525.16K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.13
Next Earnings
Jul 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,858,926
10 Day Avg. Volume120
30 Day Avg. Volume171
Financial Highlights & Ratios
PEG Ratio-19.86
Price to Book (P/B)8.70
Price to Sales (P/S)0.00
P/FCF Ratio-24.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Entheon Biomedical News
PremiumCompany Announcements
Entheon Biomedical Announces Board Changes
PremiumCompany Announcements
Entheon Biomedical Grants Incentive Stock Options to Directors
PremiumCompany Announcements
Entheon Biomedical Ends Acquisition Agreement with Mentis AI
PremiumCompany Announcements
Entheon Biomedical Secures $500,000 in Private Placement
PremiumCompany Announcements
Entheon Biomedical Announces New Private Placement FinancingPremiumCompany Announcements
Entheon Biomedical Completes $147.5K Private PlacementPremiumCompany Announcements
Entheon Biomedical’s Strategic Financing InitiativeOptions Prices
Currently, No data available
---
Ownership Overview
15.59% Insiders
―
Mutual Funds
― Other Institutional Investors
84.41% Public Companies and
Individual Investors
1XU FAQ
What was Entheon Biomedical’s price range in the past 12 months?
Entheon Biomedical lowest stock price was €0.04 and its highest was €0.26 in the past 12 months.
What is Entheon Biomedical’s market cap?
Entheon Biomedical’s market cap is $971.03K.
When is Entheon Biomedical’s upcoming earnings report date?
Entheon Biomedical’s upcoming earnings report date is Jul 29, 2025 which is in 45 days.
How were Entheon Biomedical’s earnings last quarter?
Currently, no data Available
Is Entheon Biomedical overvalued?
According to Wall Street analysts Entheon Biomedical’s price is currently Overvalued.
Does Entheon Biomedical pay dividends?
Entheon Biomedical does not currently pay dividends.
What is Entheon Biomedical’s EPS estimate?
Entheon Biomedical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Entheon Biomedical have?
Entheon Biomedical has 13,858,926 shares outstanding.
What happened to Entheon Biomedical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Entheon Biomedical?
Currently, no hedge funds are holding shares in DE:1XU
Company Description
Entheon Biomedical
Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Technical Analysis
Cybin
―
Braxia Scientific
―
Lexston Life Sciences Corp.
―
Doseology Sciences
―
Lophos Holdings, Inc.
―